Operating Cash Flow (Statement)

$24.02M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$24.02Mperiod endingJun 30, 2026

LGND Quarterly Cash from Operations (-$2.80M → $24.02M)

Quarterly operating cash flow (statement)

High-resolution chart · PNG

LGND operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	3,663,000
Mar 31, 2001	-13,142,000
Dec 31, 2000	-9,150,000
Sep 30, 2000	-15,584,000
Jun 30, 2000	-8,758,000
Mar 31, 2000	-13,863,000
Dec 31, 1999	-10,200,000
Sep 30, 1999	-14,300,000
Jun 30, 1999	-14,000,000
Mar 31, 1999	-22,000,000
Dec 31, 1998	-16,500,000
Sep 30, 1998	-18,300,000
Jun 30, 1998	-11,700,000
Mar 31, 1998	-20,100,000
Dec 31, 1997	13,000,000
Sep 30, 1997	-10,200,000
Jun 30, 1997	-8,000,000
Mar 31, 1997	-8,200,000
Dec 31, 1996	-6,300,000
Sep 30, 1996	-10,000,000
Jun 30, 1996	-8,800,000
Mar 31, 1996	-8,200,000
Dec 31, 1995	-4,500,000
Mar 31, 1995	-2,900,000
Dec 31, 1994	-4,200,000
Sep 30, 1994	-3,000,000
Jun 30, 1994	-4,300,000
Mar 31, 1994	-2,800,000